The tumor-suppressive roles of AMPK were pharmacologically demonstrated by the application of metabolic inhibitors such as the anti-diabetic metformin and the mimetic of AMP, AICAR [4–6]. This evidence concerns the gene PRKAA1 and neoplasm.